![](https://endpts.com/wp-content/uploads/2022/11/Lonnie-Moulder-Zenas.jpg)
Lonnie Moulder, Zenas BioPharma CEO
Autoimmune biotech Zenas files for IPO amid summer lull for public debuts
Zenas BioPharma filed for an initial public offering on Thursday, marking a rare move for biotech startups this summer.
The late …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.